Key Takeaways
- Cerebras (CBRS) shares have declined significantly from their post-IPO peak of $300, hovering near $211 during Monday’s early premarket session
- Six Wall Street analysts launched coverage with Buy/Outperform recommendations and price objectives between $250 and $300
- The company commands a massive $24.6 billion order backlog, primarily driven by a substantial cloud agreement with OpenAI and a partnership with AWS
- Cerebras’ Wafer-Scale Engine represents the industry’s largest commercially available chip, specifically designed for rapid AI inference tasks
- Trailing twelve-month revenue reached $510 million with 76% year-over-year expansion, though shares command a premium 225x earnings valuation
The AI semiconductor company Cerebras Systems experienced a volatile market entry. After going public last month, the chipmaker’s shares quickly soared beyond $300 before pulling back substantially.
CBRS traded around $211.80 during Monday’s premarket hours, climbing approximately 5.4% for the session, yet remaining considerably below its initial peak. The preceding week witnessed a 6.7% decline as semiconductor stocks faced broader market pressure.
Now, a series of analyst initiations has emerged — and the investment community believes the current valuation presents an opportunity.
Mizuho analyst Vijay Rakesh launched coverage with an Outperform designation and $300 price objective. Wedbush’s Matt Bryson established a Buy rating with a $270 target. Barclays assigned an overweight recommendation with a $280 forecast. Both UBS and Rosenblatt set their sights at $300. Morgan Stanley took the most cautious stance, initiating with an overweight rating and $250 price target.
That represents a chorus of bullish sentiment from Wall Street in a single session.
Cerebras’ Unique Value Proposition
The foundation of the optimistic outlook centers on the company’s chip technology. Cerebras manufactures what’s known as a Wafer-Scale Engine — effectively the largest commercially available semiconductor in existence. It’s purpose-built for AI inference operations, which involve running trained models to produce results.
In contrast to Nvidia’s methodology, which connects thousands of smaller GPUs through sophisticated networking infrastructure, Cerebras consolidates everything onto a single enormous chip. This eliminates substantial overhead and accelerates token generation speeds.
“With the industry focused on inference to deliver Agentic AI solutions, we see Cerebras well-positioned as the industry leader in fast inference,” Mizuho’s Rakesh wrote.
Wedbush characterized the architecture as differentiated and observed that the market is “now learning to pay for speed” in AI inference.
The Order Book — and Customer Concentration Concerns
Cerebras disclosed a revenue backlog totaling $24.6 billion at the close of 2025. That figure commands attention. However, there’s a complication: the majority stems from a single agreement with OpenAI.
This customer concentration has raised eyebrows among certain investors. Nevertheless, the firm also secured a contract with Amazon Web Services, which introduces at least one additional major customer and provides some reassurance regarding revenue diversification.
Wedbush’s Bryson positioned it this way: “With a differentiated architecture, a step-change in contracted revenue from OpenAI and AWS, and a market only now learning to pay for speed, we see an asymmetric, upside-skewed setup.”
His $270 price objective derives from 40 times his projected 2028 earnings, adjusted for net cash.
Trailing twelve-month revenue totaled $510 million, reflecting 76% year-over-year growth. The stock commands a 225x earnings multiple, which InvestingPro identified as elevated relative to fair value.
At Monday’s premarket level near $211, CBRS had gained roughly 14% during the session by mid-morning, per updated market data.


